GlassScriptPhysician profile
Steven F Berkey
NPI 1588660294
$1,555.42
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,534 · 2020: $21.15.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,115.00 | 2019 | |
| Smith+Nephew, INC. | $161.20 | 2019 | |
| Trilliant Surgical LLC. | $37.22 | 2019 | |
| Tactile Systems Technology INC | $35.96 | 2019 | |
| Melinta Therapeutics, LLC | $29.99 | 2019 | |
| Acell, INC. | $26.67 | 2019 | |
| Novum Pharma, LLC | $21.52 | 2019 | |
| Misonix INC | $21.15 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $18.08 | 2019 | |
| Ermi LLC | $18.03 | 2019 | |
| Medline Industries LP | $16.54 | 2019 | |
| Zimmer Biomet Holdings, INC. | $14.59 | 2019 | |
| Allergan, INC. | $13.65 | 2019 | |
| Convatec INC. | $13.35 | 2019 | |
| Djo, LLC | $12.47 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Berkey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.